During the past decade, Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" #1 collaborator was "German Cancer Research Center" with 1 trials as a collaborator, "Neuro-Oncology Working Group of the German Cancer Society" with 1 trials as a collaborator and "University Hospital Heidelberg" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are "Glioblastoma" (1 trials), "Glioma" (1 trials), "Malignant Glioma" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" in a lesser frequency.

Most popular intervention types in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials), "IDH1 peptide vaccine" (1 trials) and "IDH1R132H peptide vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".